key: cord-0960610-z5koc4o9
authors: Bello-Chavolla, Omar Yaxmehen; Antonio-Villa, Neftali Eduardo; Vargas-Vázquez, Arsenio; Fermín-Martínez, Carlos A; Márquez-Salinas, Alejandro; Bahena-López, Jessica Paola
title: Profiling cases with non-respiratory symptoms and asymptomatic SARS-CoV-2 infections in Mexico City
date: 2020-08-28
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1288
sha: 92ef621c18fbcea48cb0d9bcbec23d0fe8ac92d9
doc_id: 960610
cord_uid: z5koc4o9

We profiled cases with non-respiratory symptoms (NRS) and asymptomatic SARS-CoV-2 assessed within Mexico City’s Epidemiological Surveillance System. We show that initially asymptomatic or NRS cases have decreased risk of adverse COVID-19 outcomes compared to cases with respiratory symptoms. Comorbidity and age influence likelihood of developing symptoms in initially asymptomatic cases.

Asymptomatic infections are a potential source of rapid SARS-CoV-2 spread 1 . Prevalence of pre-symptomatic/asymptomatic cases varies widely but represent a larger proportion of cases than previously anticipated 2 . Controversies surrounding asymptomatic SARS-CoV-2 infections have focused on the distinction between pre-symptomatic and asymptomatic infection and its definitions; nevertheless, longitudinal data shows that only a fraction of initially asymptomatic infections develop subsequent symptoms 3, 4 . In Mexico, SARS-CoV-2 testing focuses on sampling high-risk cases with suspected COVID-19 by the presence of RS, which has allowed characterization of increased susceptibility for severe attributable to cardio-metabolic comorbidities 5 ; however, no data has been reported on cases with non-respiratory symptomatology (NRS) and asymptomatic SARS-CoV-2 infections, which are underrepresented under the current testing framework in Mexico. Lack of information regarding cases with NRS, or initially asymptomatic cases in Mexico is concerning, particularly since many studies suggest that contact tracing of asymptomatic infections will be pivotal to contain further SARS-CoV-2 spread and the likelihood of underreporting cases without respiratory symptoms but with NRS 6 . Here, we profile patients with NRS and initially asymptomatic SARS-CoV-2 infections to assess outcomes after follow-up using cases detected in Mexico City.

We analyzed data from the National Epidemiological Surveillance System in the Greater Mexico City area, an open-source dataset comprising daily updated cases tested using realtime RT-PCR to confirm SARS-CoV-2 using nasopharyngeal swabs according to the Berlin Protocol 7 . For analysis, we propose two main symptom groups, which we confirmed using correspondence analyses to cluster symptoms with comparable similarity (Supplementary Material): RS included dyspnea, polypnea or cyanosis at initial evaluation, but we also included fever and cough in this group based on WHO criteria for suspected COVID-19 cases; whilst NRS included headache, myalgias, arthralgias, general malaise, abdominal pain, chest pain, conjunctivitis, irritability or vomiting. We defined cases with RS as those 

As of 19 th August 2020, a total of 296,157 subjects were tested for SARS-CoV-2 in Mexico City. From 108,080 cases with confirmed SARS-CoV-2 infection (PR 36.5%), 14,657cases did not have RS (13.6%). Overall, 37,356 NRS cases had been evaluated, amongst whom 

Amongst initially asymptomatic patients with SARS-CoV-2 infection (n=6,112), 185 were eventually hospitalized (3.0%), 12 required MVS (0.2%) and 29 required ICU admission (0.5%). We recorded 32 deaths (0.5%) amongst whom 11 deaths were ambulatory (0.2%) and 21 were hospitalized (0.3%). Predictors for severe COVID-19 included age >60 years, CKD, and reduced risk associated to previous exposure to suspected viral cases; predictors of lethality included age >60 years and CKD. As of August 19 th 2020, 415 patients were still under domiciliary surveillance (6.8%), 91 remained hospitalized (1.5%), 71 were discharged after recovery (1.2%), 2 had a voluntary discharge, and 5,501 had completed follow-up without developing symptoms which required hospitalization (90.0%).

Compared to initially asymptomatic cases, symptomatic cases were associated with older age, reduced previous viral exposure, healthcare workers, diabetes, obesity, hypertension, CKD, COPD, asthma and smoking. Similarly, compared to NRS, RS cases were associated A c c e p t e d M a n u s c r i p t 6 with asthma, immunosuppression, COPD, older age, male sex, diabetes, obesity, hypertension, reduced previous viral exposure with a reduced likelihood associated with smoking (Figure 2) . Compared to initially asymptomatic cases, risk of severe COVID-19 was significantly higher for both NRS (HR 1.56, 95%CI 1.14-2.13) and RS cases (HR 4.78, 95%CI 3.67-6.21), adjusted for age, sex and comorbidities. Similarly, NRS and RS had higher mortality compared to asymptomatic cases (Breslow-Cox p<0.001, Figure 2) ; adjusting for age, sex and comorbidities, NRS (HR 2.32, 95%CI 1.57-3.43) or RS cases (HR 6.50, 95%CI 4.59-9.21) retained higher mortality compared to initially asymptomatic cases.

Here, we present a comprehensive report of COVID-19 cases with NRS and initially asymptomatic SARS-CoV-2 infections in Mexico City. Early detection of SARS-CoV-2 infections in initially asymptomatic patients or who present with NRS would help to reduce the spread of SARS-CoV-2 in Mexico, as these patients have lower risk of subsequent complications, as shown in this study, and would benefit the most from domiciliary treatment and prompt isolation. We also report a low prevalence of cases who were initially classified as asymptomatic but eventually were hospitalized or had outcomes related to severe COVID-19 8 . This data confirms observations from other populations regarding the course of COVID-19 cases with NRS and initially asymptomatic SARS-CoV-2 infections 3 . Our study also highlights the relevance of extending testing to cases with NRS and initially asymptomatic cases within the testing framework in Mexico; identifying asymptomatic cases is of importance given conflicting evidence on viral shedding for these cases, and data suggesting evidence of subclinical lung abnormalities which must be assessed longitudinally to rule out long-term impacts of SARS-CoV-2 infection 9 . Notably, a consistent predictor of outcomes for NRS cases and initially asymptomatic cases were previous exposure to suspected viral cases, highlighting the relevance of contact tracing and prompt case identification but also confirming that cases presented in our study are not representative of all asymptomatic infections but mostly of those identified by contact tracing, likely underestimating rates of true asymptomatic cases. epidemic. Its participation in the COVID-19 surveillance program has made this work a reality, we are thankful for your effort. All data sources and R code are available for reproducibility of results at https://github.com/oyaxbell/covid_asymptomatic_cdmx. 

The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis. medRxiv

Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review

Natural History of Asymptomatic SARS-CoV-2 Infection

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo

Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico

Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies

Covid-19 SINAVE Ciudad de México -Datos CDMX

CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Probability of symptoms and critical disease after SARS-CoV-2 infection

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy

Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes

A c c e p t e d M a n u s c r i p t 9 A c c e p t e d M a n u s c r i p t